Synthesis and Biological Activity of 4-ARYL-2-[(2-OXO-1,2-Diphenylethylidene)-Hydrazinyl]-4-Oxobut-2-Enoic-Acid Amides
- Authors: Bykov R.A.1, Trapeznikova N.N.2, Balandina S.Y.1, Komarova O.A.1, Makhmudov R.R.1, Pulina N.A.3, Sobin F.V.1, Rubtsov A.E.1
- 
							Affiliations: 
							- Perm State National Research University
- D. N. Pryanishnikov Perm State Agricultural Academy
- Perm State Pharmaceutical Academy, Ministry of Health of the Russian Federation
 
- Issue: Vol 52, No 5 (2018)
- Pages: 415-418
- Section: Article
- URL: https://ogarev-online.ru/0091-150X/article/view/245223
- DOI: https://doi.org/10.1007/s11094-018-1833-2
- ID: 245223
Cite item
Abstract
4-Aryl-2-[(2-oxo-1,2-diphenylethylidene)hydrazinyl]-4-oxobut-2-enoic-acid amides were produced via decyclization of 3-[(2-oxo-1,2-diphenylethylidene)hydrazono]-5-arylfuran-2(3H)-ones by the corresponding amines and via reaction of 4-aryl-2-hydroxy-4-oxobut-2-enoic-acid hetarylamides with 2-hydrazono-1,2-diphenylethanone. Their analgesic and antibacterial activities were studied. Compounds with low toxicities and activities comparable to and exceeding those of reference drugs were discovered.
About the authors
R. A. Bykov
Perm State National Research University
														Email: rubtsov@psu.ru
				                					                																			                												                	Russian Federation, 							15 Bukireva, Perm, 614036						
N. N. Trapeznikova
D. N. Pryanishnikov Perm State Agricultural Academy
														Email: rubtsov@psu.ru
				                					                																			                												                	Russian Federation, 							53 Petropavlovskaya, Perm, 614990						
S. Yu. Balandina
Perm State National Research University
														Email: rubtsov@psu.ru
				                					                																			                												                	Russian Federation, 							15 Bukireva, Perm, 614036						
O. A. Komarova
Perm State National Research University
														Email: rubtsov@psu.ru
				                					                																			                												                	Russian Federation, 							15 Bukireva, Perm, 614036						
R. R. Makhmudov
Perm State National Research University
														Email: rubtsov@psu.ru
				                					                																			                												                	Russian Federation, 							15 Bukireva, Perm, 614036						
N. A. Pulina
Perm State Pharmaceutical Academy, Ministry of Health of the Russian Federation
														Email: rubtsov@psu.ru
				                					                																			                												                	Russian Federation, 							46 Krupskoi, Perm, 614000						
F. V. Sobin
Perm State National Research University
														Email: rubtsov@psu.ru
				                					                																			                												                	Russian Federation, 							15 Bukireva, Perm, 614036						
A. E. Rubtsov
Perm State National Research University
							Author for correspondence.
							Email: rubtsov@psu.ru
				                					                																			                												                	Russian Federation, 							15 Bukireva, Perm, 614036						
Supplementary files
 
				
			 
					 
						 
						 
						 
						 
				 
  
  
  
  
  Email this article
			Email this article  Open Access
		                                Open Access Access granted
						Access granted Subscription Access
		                                		                                        Subscription Access
		                                					